Cargando…

Importance of secondary screening with clinical isolates for anti-leishmania drug discovery

The growing drug resistance (DR) raises major concerns for the control of visceral leishmaniasis (VL), a neglected disease lethal in 95 percent of the cases if left untreated. Resistance has rendered antimonials (SSG) obsolete in the Indian Sub-Continent (ISC) and the first miltefosine-resistant Lei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hefnawy, Aya, Cantizani, Juan, Peña, Imanol, Manzano, Pilar, Rijal, Suman, Dujardin, Jean-Claude, De Muylder, Geraldine, Martin, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6078976/ https://www.ncbi.nlm.nih.gov/pubmed/30082744 http://dx.doi.org/10.1038/s41598-018-30040-5

Ejemplares similares

Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine
por: Tegazzini, Diana, et al.
Publicado: (2017)

Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinent
por: Cuypers, Bart, et al.
Publicado: (2018)

Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions
por: De Muylder, Géraldine, et al.
Publicado: (2016)

The Absence of C-5 DNA Methylation in Leishmania donovani Allows DNA Enrichment from Complex Samples
por: Cuypers, Bart, et al.
Publicado: (2020)

Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden
por: Vanaerschot, Manu, et al.
Publicado: (2011)

The adaptive roles of aneuploidy and polyclonality in Leishmania in response to environmental stress
por: Negreira, Gabriel H, et al.
Publicado: (2023)

Comparative Fitness of a Parent Leishmania donovani Clinical Isolate and Its Experimentally Derived Paromomycin-Resistant Strain
por: Hendrickx, Sarah, et al.
Publicado: (2015)

Genomic and Phenotypic Characterization of Experimentally Selected Resistant Leishmania donovani Reveals a Role for Dynamin-1-Like Protein in the Mechanism of Resistance to a Novel Antileishmanial Compound
por: Hefnawy, Aya, et al.
Publicado: (2022)

Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease
por: Roquero, Irene, et al.
Publicado: (2019)

Linking In Vitro and In Vivo Survival of Clinical Leishmania donovani Strains
por: Vanaerschot, Manu, et al.
Publicado: (2010)

Molecular Mechanisms of Drug Resistance in Natural Leishmania Populations Vary with Genetic Background
por: Decuypere, Saskia, et al.
Publicado: (2012)

Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage
por: Jara, Marlene, et al.
Publicado: (2017)

Relapse after Treatment with Miltefosine for Visceral Leishmaniasis Is Associated with Increased Infectivity of the Infecting Leishmania donovani Strain
por: Rai, Keshav, et al.
Publicado: (2013)

A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit
por: De Muylder, Geraldine, et al.
Publicado: (2011)

In Vitro Assessment of Antifungal Caspofungin on Leishmania donovani Culture Isolation
por: Bhattarai, Narayan Raj, et al.
Publicado: (2017)

Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal
por: Rai, Keshav, et al.
Publicado: (2017)

Molecular Preadaptation to Antimony Resistance in Leishmania donovani on the Indian Subcontinent
por: Dumetz, F., et al.
Publicado: (2018)

Genome-wide SNP and microsatellite variation illuminate population-level epidemiology in the Leishmania donovani species complex
por: Downing, Tim, et al.
Publicado: (2012)

Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent
por: Domagalska, Malgorzata A., et al.
Publicado: (2019)

Automated High-Content Assay for Compounds Selectively Toxic to Trypanosoma cruzi in a Myoblastic Cell Line
por: Alonso-Padilla, Julio, et al.
Publicado: (2015)

Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts
por: Ostyn, Bart, et al.
Publicado: (2015)

Non-Leishmania Parasite in Fatal Visceral Leishmaniasis–like Disease, Brazil
por: Domagalska, Malgorzata Anna, et al.
Publicado: (2020)

Application of kDNA Minicircle PCR-RFLP to Characterize Leishmania donovani Clinical Isolates Obtained from Post-Kala-Azar Dermal Leishmaniasis in Eastern Nepal
por: Pokhrel, Ojesh, et al.
Publicado: (2019)

New Compound Sets Identified from High Throughput Phenotypic Screening Against Three Kinetoplastid Parasites: An Open Resource
por: Peña, Imanol, et al.
Publicado: (2015)

Genome diversity of Leishmania aethiopica
por: Hadermann, Amber, et al.
Publicado: (2023)

Rate-of-Kill (RoK) assays to triage large compound sets for Chagas disease drug discovery: Application to GSK Chagas Box
por: Cantizani, Juan, et al.
Publicado: (2021)

Identifying inhibitors of the Leishmania inositol phosphorylceramide synthase with antiprotozoal activity using a yeast-based assay and ultra-high throughput screening platform
por: Norcliffe, Jennifer L., et al.
Publicado: (2018)

Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial
por: Picado, Albert, et al.
Publicado: (2010)

Major changes in chromosomal somy, gene expression and gene dosage driven by Sb(III) in Leishmania braziliensis and Leishmania panamensis
por: Patino, Luz H., et al.
Publicado: (2019)

Tracking of quiescence in Leishmania by quantifying the expression of GFP in the ribosomal DNA locus
por: Jara, Marlene, et al.
Publicado: (2019)

Discovery of small molecule inhibitors of Leishmania braziliensis Hsp90 chaperone
por: Batista, Fernanda A. H., et al.
Publicado: (2020)

Genomic and Metabolomic Polymorphism among Experimentally Selected Paromomycin-Resistant Leishmania donovani Strains
por: Shaw, C. D., et al.
Publicado: (2019)

Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia
por: Ostyn, Bart, et al.
Publicado: (2014)

Risk Factors for Visceral Leishmaniasis and Asymptomatic Leishmania donovani Infection in India and Nepal
por: Picado, Albert, et al.
Publicado: (2014)

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and Resistant Leishmania donovani Clinical Isolates in Experimental Infection
por: Mukherjee, Sandip, et al.
Publicado: (2012)

The identification of kala-azar and the discovery of Leishmania donovani.
por: Gibson, M E
Publicado: (1983)

Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase
por: McCall, Laura-Isobel, et al.
Publicado: (2015)

Importance of polyphosphate in the Leishmania life cycle
por: Kohl, Kid, et al.
Publicado: (2018)

Modulation of Aneuploidy in Leishmania donovani during Adaptation to Different In Vitro and In Vivo Environments and Its Impact on Gene Expression
por: Dumetz, F., et al.
Publicado: (2017)

Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani
por: Verma, Aditya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lmq209hde35ikbagvn8kmmr7m3